Photodynamic therapy using a novel photosensitizer, EC036, is more effective compared with ATX-S10(Na) photodynamic therapy.
Takahashi
Hidetoshi
H
Nakajima
Susumu
S
Asano
Ryuji
R
Nakae
Yoshinori
Y
Sakata
Isao
I
Iizuka
Hajime
H
D015127:9,10-Dimethyl-1,2-benzanthracene; D000279:Administration, Cutaneous; D000818:Animals; D005260:Female; D054023:Lasers, Semiconductor; D051379:Mice; D008812:Mice, Hairless; D009824:Ointments; D010212:Papilloma / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D010778:Photochemotherapy / Q000295:instrumentation / Q000379:methods*; D017319:Photosensitizing Agents / Q000008:administration & dosage / Q000494:pharmacology*; D011166:Porphyrins / Q000008:administration & dosage / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D013755:Tetradecanoylphorbol Acetate; D013997:Time Factors
C544479:13,17-bis(1-carboxyethyl)-3-(1,3-dioxan-2-yl)methylidene-8-ethenyl-2-hydroxy-2,7,12,18-tetramethylchlorin dimethyl ester; C117772:ATX S10Na(II); D009824:Ointments; D017319:Photosensitizing Agents; D011166:Porphyrins; D015127:9,10-Dimethyl-1,2-benzanthracene; D013755:Tetradecanoylphorbol Acetate